Fecal strongyle egg counts in horses with suspected pre-clinical pituitary pars intermedia dysfunction before and after treatment with pergolide.
Authors: Christen Garance, Gerber Vinzenz, van der Kolk Johannes Hermanus, Frey Caroline Franziska, Fouché Nathalie
Journal: Veterinary journal (London, England : 1997)
Summary
# Editorial Summary: Fecal Strongyle Egg Counts and PPID in Horses Pituitary pars intermedia dysfunction (PPID) is known to compromise immune competence in older horses, raising the question of whether affected animals might shed elevated levels of strongyle eggs as a consequence of this immunosuppression. Researchers tracked faecal egg counts (EPG) and adrenocorticotropic hormone (ACTH) levels in 48 horses, comparing pre-clinical PPID cases with healthy controls before and after pergolide treatment, using EPG as a proxy marker for immune function. Surprisingly, baseline strongyle egg shedding showed no significant differences between PPID-affected and control horses, and pergolide-treated animals demonstrated no reduction in EPG compared to placebo controls. These findings suggest that the immunological changes associated with pre-clinical PPID may not be sufficiently pronounced to measurably affect parasitic egg shedding, or alternatively that faecal EPG is too crude a marker to detect subtle immune dysfunction at this disease stage. For practitioners managing older horses with suspected PPID, these results indicate that strongyle burden cannot be assumed as a consequence of the condition and should continue to be managed according to standard parasite control protocols rather than as an anticipated complication of hormonal dysfunction.
Read the full abstract on PubMed
Practical Takeaways
- •Pre-clinical PPID does not appear to increase strongyle infection risk based on fecal egg count monitoring, so parasite control protocols need not be intensified solely on the basis of PPID status
- •Pergolide treatment in PPID cases does not alter fecal egg shedding patterns, suggesting immune function as measured by parasite burden may not be significantly compromised in early disease
- •Standard deworming and fecal monitoring protocols should continue regardless of PPID status; this finding does not justify additional antiparasitic interventions for PPID horses
Key Findings
- •No significant difference in baseline fecal egg counts (EPG) between horses with pre-clinical PPID and healthy controls
- •No significant difference in EPG between pergolide-treated and placebo-treated horses with PPID
- •Fecal egg counts did not support the hypothesis of diminished immune function in pre-clinical PPID
- •Study challenges the association between PPID and increased strongyle egg shedding as a marker of immune compromise